Abstract: Provided are a compound having a metal M and a first ligand LA comprising the structure of where the compound is capable of functioning as a phosphorescent emitter in an organic light emitting device at room temperature.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In the compound, ring B is a 5- or 6-membered ring; each of Z and X1 to X4 is C or N; Y is a linking atom; K is a direct bond or a linking atom; each R*, RA, RB, and RC is hydrogen or a General Substituent defined herein; a total of at least two of RB and/or RC substituents are independently electron-withdrawing groups; and LA is coordinated to a metal M, having an atomic mass of at least 40. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound having a metal coordination complex structure, where the compound is capable of functioning as a phosphorescent emitter in an organic light emitting device at room temperature is disclosed. The compound has a first ligand coordinated to a metal. The free-state of the first ligand has a first triplet energy T1 of EL at 77K, while the compound has a first triplet energy T1 of E at 77K, and the difference in energy (?E) between E and EL is ?250 meV. The compound has a triplet emission spectrum with a FWHM value of no more than 45 nm. Organic light emitting devices, consumer products, and formulations containing the compounds are also disclosed.

Abstract: A compound comprising a ligand LA of Formula I coordinated to a metal M as represented by the dotted lines wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring, and ring B is a multicyclic ring system comprising four to eight fused 5-membered or 6-membered, carbocyclic or heterocyclic rings; wherein the ring B includes a structure of Formula II wherein ring C is a 5-membered or 6-membered carbocyclic or heterocyclic ring, and the dotted lines of Formula II represent fusion of the structure of Formula II as part of the multicyclic ring system of ring B; T1, T2, and T3 are independently selected from N or C; and L is a linker L2-L1 with L2 and L1 independently selected from the group consisting of O, S, NRN, CR1R2, CR3R4, SiR1R2, and SiR3R4; wherein at least one of L1 or L2 is CR1CR2 or SiR1R2; and the metal M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Pd, Au, and Cu.

Abstract: This disclosure provides a compound, Ir(LA)p(LB)q(LC)r, where LA has a structure of Formula IA: LB has a structure of Formula IB: and LC is a bidentate ligand. In Formulas IA and IB, p and q are 1 or 2; r is 0 or 1; and p+q+r=3; moiety A is a monocyclic ring or a polycyclic fused ring system; Y is a linker that forms a 5-membered ring; each of Z1, Z2, and X1 to X16 is C or N; each substituent is hydrogen or a General Substituent defined herein; and at least one of RD or RE is a heterocycle, provided that (a) if RE is a heterocycle comprising one heteroatom, then p=1 and moiety A is not a fused imidazole; and (b) if one RD is pyridine, then each of X1-X8 is C. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, moiety A is a monocyclic ring or a polycyclic fused ring system, moiety B is a polycyclic fused ring system; each of Z1 to Z4 is C or N; each of K1 and K2 is a direct bond or a linker; at least one RB or RA comprises, where T is B, C, N, Si, Ge, Bi, or P; V is a direct bond or a linker; R1 and R2 are present, and R3 is optionally present; each substituent is independently hydrogen or a General Substituent defined herein; and at least two of R1, R2, and R3 has two or more carbon atoms. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, is provided, where: each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; each of X1 to X4 and Z1 and Z2 is C or N; K1 and K2 are each a direct bond or a linker; L1 is a direct bond or an organic linker; each R?, R?, RA and RB is hydrogen or a General Substituent defined herein; and at least one RA or one RB comprises R*, where R* is an alkyl group, a silyl group, a germyl group, or a combination thereof. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound of Formula Ir(LA)x(LB)y(LC)z is provided, where the first ligand LA comprises a structure of Formula I, ?the ligand LB comprises a structure of Formula II, ?and the ligand LC is a bidentate ligand. In the compound, each of A1 to A8, X1 to X4, Z1, and Z2 is C or N; at least one of X1 to X4 is N, or at least one RA is electron withdrawing group, a silyl group, a germyl group, a heteroalkyl group, a cycloalkyl group, a hetrocycloalkyl group, an alkyl group having three or more carbon atoms, or combinations thereof; Y is a linking group; moiety C is a monocyclic ring or a polycyclic fused ring system; and each R, R?, R1, R2, R3, R4, RA, RB, RC, and RD is hydrogen or a General Substituent defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: The present invention includes a novel series of host materials for OLEDs based on substituted fused 1,2,4-triazines, represented by Formula I. The invention also includes an organic light-emitting device comprising an anode, a cathode, and an organic layer, disposed between the anode and the cathode, comprising a compound of Formula I. The compounds of the invention may improve the device EQE and lifetime.

Abstract: An OLED including an organic layer that contains metal complex compounds that are useful as a phosphorescent emitter is disclosed. The metal complex compounds include ligands that incorporate fluorinated side chains and has at least one substituent R selected from the group consisting of partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof, wherein R is directly bonded to an aromatic ring, In the compound, C having an F attached thereto is separated by at least one carbon atom from the aromatic ring.

Abstract: New organometallic complexes having bis- or tris-heteroleptic ligands and large aspect ratio in one direction and their use in OLEDs to enhance the efficiency is disclosed. Such compounds can have a structure of Formula III, where rings A, B, C, and D are ring; L1 and L3 each a direct bond or a linking group; n1 and n2 are 0 or 1; if n1 or n2 is 1, then L2 or L4 is a direct bond or a linking group, and if n1 or n2 is 0, L2 or L4 is not present; Q1, Q2, Q3 and Q4 are a direct bond or oxygen; ring A is trans to ring D, ring B is trans to ring C in a square-planar coordination configuration; M2 is Pt, and the compound comprises at least one Pt-carbene bond.

Abstract: Provided are organometallic compounds comprising two moieties A and B which are each independently a monocyclic ring or a polycyclic fused ring structure, wherein the monocyclic ring or each ring of the polycyclic fused ring structure is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring which are linked by a direct bond and which are further bridged by a linker comprising two groups which are each independently selected from the group consisting of O, S, Se, NR, BR, BRR?, PR, CR, C?O, C?NR, C?CRR?, C?S, CRR?, SO, SO2, P(O)R, SiRR?, and GeRR?. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: A compound having a structure of Formula I, is provided. In Formula I, X1-X7, Z1 and Z2 are each independently C or N; Z3 is selected from BR?, NR?, PR?, O, S, Se, C?O, S?O, SO2, CR?R?, SiR?R?, and GeRR?; L is selected from O, S, and NR; C1, C2, and C3 are all carbon atoms; the bonds represent single bond or double bond to fulfill the valency requirement of a neutral compound; each R1, R2, R3, R, R?, R?, RA, and RB is independently hydrogen or a substituent; and any two of R1, R2, R3, R, R?, R?, RA, and RB can be joined or fused together to form a ring. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound comprising a hexadentate ligand of Formula I coordinated to a metal selected from the group consisting of iridium, rhodium, and osmium; wherein rings A, B, C, D, E, and F are independently a 5-membered or 6-membered heteroaryl ring, or a 6-membered aryl ring; T1, T2, T3, T4, T5, and T6 are independently selected from C or N, wherein two to four of T1 to T6 are C, and two to four of T1 to T6 are N; Z1, Z2, Z3, and Z4 are independently selected from C or N, wherein if Z1 and Z2 are each N then T1 is a carbene carbon and two of T2 to T6 are N; Y1 and Y2 are independently selected from the group consisting of CR, SiR, B, or N; W1-W7 are independently selected from the group consisting of a direct bond, BR, BRR?, NR, PR, O, S, Se, C?X, S?O, SO2, CR, CRR?, SiRR?, GeRR?, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof; wherein X is selected from the group consisting of O, S, Se, NR?, and CR?R??; RA to RF independently represent mono to the maximum allowable substitution, or no substitu

Abstract: Provided are organometallic compounds comprising an Ir atom as the central metal atom which is coordinated by two three-dentate ligands. Also provided are formulations comprising these organometallic compounds comprising an Ir atom. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds comprising an Ir atom.

Abstract: A compound comprising a first bidentate ligand LA, wherein LA comprises a structure of Formula I; wherein Z is selected from the group consisting of O, S, NR, BR, CRKRL, SiRKRL, —CRKRLCRMRN—, —SiRKRLSiRMRN—, —CRKRLO—, —SiRKRLO—, and —CRK?CRL—; wherein ring A, ring B, and ring C are each independently a 5-membered carbocyclic ring, 5-membered heterocyclic ring, 6-membered carbocyclic ring or 6-membered heterocyclic ring; wherein LA is coordinated to a metal M forming a 5-membered chelate ring; wherein M is selected from the group consisting of Ir, Pt, Pd, Ru, Rh, Os, Re, Cu, Ag, and Au; wherein RA, RB, and RC each represent mono to the maximum allowable substitution, or no substitution; wherein each R, RK, RL, RM, RN, RA, RB, and RC is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, car

Abstract: Compounds of Formula I, are provided.

Abstract: A compound having a formula of Ir(LA)n(LB)m(LC)o, wherein first ligand LA comprises a structure of Formula I, LB comprises a structure of Formula IIA, or Formula IIB, and LC is a bidentate ligand. In these structures, n is 1 or 2, m is 1 or 2, o is 0 or 1, and m+n+o=3; each of moiety A, moiety D, and moiety F is a monocyclic ring or polycyclic fused ring system; moiety B is a polycyclic fused ring system; each of Z1 to Z6 and X1 to X7 is C or N; Y1 is O, S, Se, Te, P, Si, and Ge; and each RA, RB, RC, RD, RE, and RF is hydrogen or a General Substituent. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are organometallic compounds wherein a boron containing group bridges two monocyclic or fused polycyclic ring systems each independently comprised of one or more 5-membered or 6-membered rings. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.